Actively Recruiting
Dietary Intervention to Improve Fertility in Women With Endometriosis Undergoing IVF
Led by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Updated on 2025-03-27
438
Participants Needed
1
Research Sites
249 weeks
Total Duration
On this page
Sponsors
F
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Lead Sponsor
U
Université Catholique de Louvain
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this randomized controlled trial is to assess whether a 12-week anti-inflammatory diet can improve fertility outcomes in women with endometriosis undergoing In Vitro Fertilization (IVF). The main questions are: * Does the anti-inflammatory diet reduce the rate of inadequate ovarian response to hormonal stimulation (retrieval of ≤3 oocytes)? * Does it improve secondary outcomes such as embryo quality, pregnancy rates, inflammation markers, and quality of life? Researchers will compare two groups: * Women receiving standard IVF protocols. * Women undergoing the same IVF protocol plus the anti-inflammatory diet. Participants will: * Be randomized into one of the two groups. * Follow dietary counseling sessions and complete dietary assessments (diet group). * Provide biological samples (e.g., plasma, vaginal and fecal swabs, and follicular fluid) before and after the dietary intervention to evaluate potential differences in inflammation, hormonal levels, and microbiome composition between the two groups and across timepoints (pre- and post-diet). * Complete questionnaires on quality of life, sexual function, and symptomatology severity before and after the intervention to assess differences between the two groups and across timepoints.
CONDITIONS
Official Title
Dietary Intervention to Improve Fertility in Women With Endometriosis Undergoing IVF
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age under 40 years
- Seeking pregnancy for more than 12 months
- Regular menstrual cycles with intervals between 21 and 35 days
- Ultrasonographic diagnosis of ovarian endometriomas or deep peritoneal endometriosis
- Antral Follicle Count of 5 or more with no other cause of reduced ovarian reserve
- No ureteral stenosis or intestinal subocclusive symptoms
You will not qualify if you...
- Contraindication to pregnancy
- Presence of hydrosalpinx
- Endometriomas larger than 4 cm in diameter
- Submucosal fibroids or large intramural or subserosal fibroids 5 cm or larger
- Uncertain sonographic findings that do not rule out malignancy
- Severe male factor infertility with sperm count below 1 million/ml
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy, 20122
Actively Recruiting
Research Team
P
Paola Vigano', PhD
CONTACT
M
Marco Reschini, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here